Global DNA and Gene Chip Market Analysis & Trends - Industry Forecast to 2030
DNA and Gene Chip: Market Size
From $10.4 billion in 2024, the global DNA and Gene Chip market is projected to reach $24.8 billion by 2030. Based on our analysis the market is expected to grow at a CAGR of 15.6% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include increasing government funding for genomics research, rising demand for personalized diagnosis and treatment for cancer, and less complexity of microarrays as compared with other sequencing technologies.
Global DNA and Gene Chip Market: Market Dynamics
The growth of personalized medicines, robotics, and fabrication methods for microarrays and the rapid growth of microarray technology in computational capabilities are driving the market growth.
On the other hand, the lack of technically skilled employees is likely to obstruct the profit boundaries. In addition, technological advancements in DNA microarrays to expand their application in biomedicine will further boost the DNA and Gene Chip market.
Impact of COVID-19 on DNA and Gene Chip
The genome of COVID-19 virus constitutes 29,903 nucleotides which upon fresh reannotation and mapping of the RNA-sequences obtained, presented the 123,613 reads assembly and was very similar to SL-CoVZC45—an already known bat strain and SARS-CoV. This group of viruses can easily undergo mutation and recombination to adapt to any environment and thus survive by altering a wide host range causing constant and long-term health threats. Therefore, rapid, on-the-spot, and accurate screening of potential virus carriers along with critical observation of patients without any indicative symptoms is very much essential for controlling the spread of COVID-19. Thus, the various detection methods available for the detection of COVID-19, their advantages, disadvantages, and urgent need for a rapid POC detection method, on-the-spot biosensor their feasibly and importance in the presence of ever-increasing countdown of COVID- 19 infected patients.
By End User
Academic and Government Research Institutes Segment Dominate the Market in 2024
The academic and government research institutes segment made huge revenue in 2024 during the forecast period as they use the microarrays to discover newer unconventional fields in which informatics can be used to improve the procedures due to which the highest growth rates have been registered in this particular field.
By Geography
North America Region is Leading in the Global Market Place
North America region is likely to have a huge demand in the forecast period owing to factors such as the presence of well-established players, advanced informatics infrastructure, presence of experts and skilled workforce, and ongoing genomic R & D practices on a large scale.
List of the Key Players Profiled in the Market Include: • Thermo Fisher Scientific, Inc
• Greiner Bio One International GmbH
• Perkin Elmer, Inc.
• Microarrays Inc
• Illumina, Inc
• Merck KGaA
• Biometrix Technology Inc
• Shanghai Biochip Co Ltd
• Savyon Diagnostics
• Agilent Technologies
List of the Regions/Countries Profiled in the Market Include: North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others